ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
256.00
-0.57 (-0.22%)
Oct 29, 2025, 11:45 AM EDT - Market open
ResMed Revenue
In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.
Revenue (ttm)
$5.15B
Revenue Growth
+9.84%
P/S Ratio
7.31
Revenue / Employee
$515,664
Employees
9,980
Market Cap
37.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
RMD News
- 19 days ago - Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 - GlobeNewsWire
- 26 days ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha
- 5 weeks ago - ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 6 weeks ago - Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025 - GlobeNewsWire
- 7 weeks ago - Top 50 High-Quality Dividend Stocks For September 2025 - Seeking Alpha
- 7 weeks ago - Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority - GlobeNewsWire
- 2 months ago - Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds - GlobeNewsWire
- 2 months ago - ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows - Seeking Alpha